Riders · Health and Human Services Commission · Article II: Health and Human Services

Stroke Treatment and Response

Rider 95 in the 2026-27 Act, page II-78

2028-29 request. Health and Human Services Commission has asked to update the years in this rider, and nothing else. What it asked for. A request, not law.

Through the session

  1. 2024-25 Act Not in this version
  2. Introduced (Senate) New rider 69
  3. Introduced (House) New rider 68
  4. Senate substitute Unchanged rider 69
  5. House substitute Unchanged rider 68
  6. House passed Unchanged rider 68
  7. Conference Unchanged rider 95
  8. 2026-27 Act Unchanged rider 95

Pick any two steps to compare their wording.

What changed in the text

Conference → 2026-27 Act: the same text in both versions.

Stroke Treatment and Response. (a) Included in amounts appropriated above in Strategy D.1.10, Additional Specialty Care, is $2,500,000 from the General Revenue Fund in fiscal year 2026 and $2,500,000 from the General Revenue Fund in fiscal year 2027 for the Health and Human Services Commission (HHSC) to provide funding for services provided by mobile stroke units. (b) It is the intent of the Legislature that, out of funds appropriated above in Goal A, Medicaid Client Services, HHSC shall reimburse for tissue plasminogen activator (tPA) for treatment of stroke.

Removed words are struck through; added words are underlined. Sources: Conference · 2026-27 Act.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium Not in this version
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) 69 New — Page II-88
Introduced (House)House Bill 1 as introduced (LBB recommended, House) 68 New — Page II-87
Senate substituteCommittee Substitute for Senate Bill 1 69 Unchanged New Page II-70
House substituteHouse Committee Substitute for Senate Bill 1 68 was 69 Unchanged New Page II-68
House passedSenate Bill 1 as passed the second house 68 Unchanged New Page II-68
ConferenceConference Committee Report for Senate Bill 1 95 was 68 Unchanged New Page II-78
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 95 Unchanged New Page II-78
Full text of each wording

Introduced (Senate), Senate substitute, House substitute, House passed, Conference, 2026-27 Act

Source, page II-78

Stroke Treatment and Response.

(a) Included in amounts appropriated above in Strategy D.1.10, Additional Specialty Care, is $2,500,000 from the General Revenue Fund in fiscal year 2026 and $2,500,000 from the General Revenue Fund in fiscal year 2027 for the Health and Human Services Commission (HHSC) to provide funding for services provided by mobile stroke units.

(b) It is the intent of the Legislature that, out of funds appropriated above in Goal A, Medicaid Client Services, HHSC shall reimburse for tissue plasminogen activator (tPA) for treatment of stroke.

Introduced (House)

Source, page II-87

Stroke Treatment and Response.

(a) Included in amounts appropriated above in Strategy D.1.10, Additional Specialty Care, $2,500,000 from the General Revenue Fund in fiscal year 2026 and $2,500,000 from the General Revenue Fund in fiscal year 2027 for the Health and Human Services Commission (HHSC) to provide funding for services provided by mobile stroke units.

(b) It is the intent of the Legislature that, out of funds appropriated above in Goal A, Medicaid Client Services, HHSC shall reimburse for tissue plasminogen activator (tPA) for treatment of stroke.